Bitter gourd (Momordica charantia L.) supplementation for twelve weeks improves biomarkers of glucose homeostasis in a prediabetic population

被引:0
作者
Mes, Jurriaan J. [1 ]
van den Belt, Maartje [1 ]
van der Haar, Sandra [1 ]
Oosterink, Els [1 ]
Luijendijk, Teus [2 ]
Manusama, Koen [3 ]
van Dam, Lotte [3 ]
de Bie, Tessa [3 ]
Witkamp, Renger [3 ]
Esser, Diederik [1 ]
机构
[1] Wageningen Food & Biobased Res, Food Hlth & Consumer Res, Bornse Weilanden 9, NL-6708 WG Wageningen, Netherlands
[2] Stichting Control Food & Flowers, Distributieweg 1, NL-2645 EG Delfgauw, Netherlands
[3] Wageningen Univ & Res, Div Human Nutr & Hlth, Stippeneng 4, NL-6708 WE Wageningen, Netherlands
关键词
Momordica charantia; Bitter gourd; Prediabetic; Type 2 diabetes mellitus; Fasting plasma glucose; Clinical trial; Safety; TYPE-2; METFORMIN; REMISSION;
D O I
10.1016/j.jep.2025.119756
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Bitter gourd (Momordica charantia L.) is known for its ability to reduce parameters of diabetes, but its effects on prediabetic subjects have been scarcely studied. Aim of the study: To assess the efficacy of Momordica charantia supplementation in a prediabetic population on markers of glucose homeostasis. Methods: Two randomized controlled studies were conducted to assess the effect of bitter gourd supplementation in a prediabetic population. Study 1 was a 4-week cross-over intervention trial (n = 30), with freeze-dried bitter gourd (BG) fruit juice (2.4 g/day) or a cucumber-based control product (CC). Study 2 was a parallel trial (n = 38) lasting 12 weeks, with freeze-dried whole fruits (3.6 g/day) or a cucumber-based matched control supplement. Effects on fasting plasma glucose (FPG), insulin, HbA1c, fructosamine, postprandial glucose after an oral glucose tolerance test, and several safety biomarkers were also analyzed in both trials before and after the interventions. Results: In Study 1, no significant differences were found between the bitter gourd and placebo interventions. However, a reduction in FPG in subjects with higher baseline values were found following bitter gourd supplementation, which was not observed in the control group. However, in Study 2, we observed significant reductions of FPG (p = 0.014), fasting insulin (p = 0.007), and HOMA-IR (p = 0.003) after a 12-week intervention with the bitter gourd supplement. In addition, between treatment analysis resulted in significant effects on FPG levels (p = 0.026) and HOMA-IR (p = 0.045) with no significant effects on other biomarkers related to glucose metabolism. On average, bitter gourd intervention reduced FPG by similar to 0.05 mmol/L per week, whereas FPG remained unchanged following placebo. In both studies, there were no indications of health risks or side effects from consumption of the supplements. Conclusion: Results suggest that supplementation with bitter gourd fruit can have positive effects on fasting plasma glucose and insulin among prediabetic subjects when provided over an extended period of at least 12 weeks.
引用
收藏
页数:9
相关论文
共 33 条
[1]   World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects [J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (20) :2191-2194
[2]   Outcome of lifestyle intervention in relation to duration of pre-diabetes: the Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) study [J].
Dagogo-Jack, Samuel ;
Umekwe, Nkiru ;
Brewer, Amy A. ;
Owei, Ibiye ;
Mupparaju, Vamsee ;
Rosenthal, Renate ;
Wan, Jim .
BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (02)
[3]  
Demmers A., 2023, Fortune J. Health. Sci., V6, P222, DOI [10.1101/2022.10.22.22281390, DOI 10.1101/2022.10.22.22281390]
[4]   Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens, Especially Mycobacterium tuberculosis [J].
Ferlita, Steve ;
Yegiazaryan, Aram ;
Noori, Navid ;
Lal, Gagandeep ;
Nguyen, Timothy ;
To, Kimberly ;
Venketaraman, Vishwanath .
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (12)
[5]   Sodium-Glucose Cotransporter 2 Inhibitors Mechanisms of Action: A Review [J].
Fonseca-Correa, Jorge I. ;
Correa-Rotter, Ricardo .
FRONTIERS IN MEDICINE, 2021, 8
[6]   Effect of metformin in pediatric patients with type 2 diabetes - A randomized controlled trial [J].
Jones, KL ;
Arslanian, S ;
Peterokova, VA ;
Park, JS ;
Tomlinson, M .
DIABETES CARE, 2002, 25 (01) :89-94
[7]   Not Control but Conquest: Strategies for the Remission of Type 2 Diabetes Mellitus [J].
Kim, Jinyoung ;
Kwon, Hyuk-Sang .
DIABETES & METABOLISM JOURNAL, 2022, 46 (02) :165-180
[8]   Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus [J].
Kim, Soo Kyoung ;
Jung, Jaehoon ;
Jung, Jung Hwa ;
Yoon, NalAe ;
Kang, Sang Soo ;
Roh, Gu Seob ;
Hahm, Jong Ryeal .
COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 52
[9]   Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin [J].
Knowler, WC ;
Barrett-Connor, E ;
Fowler, SE ;
Hamman, RF ;
Lachin, JM ;
Walker, EA ;
Nathan, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (06) :393-403
[10]   Momordica charantia fruit reduces plasma fructosamine whereas stems and leaves increase plasma insulin in adult mildly diabetic obese Gottingen Minipigs [J].
Koopmans, Sietse Jan ;
Binnendijk, Gisabeth ;
Ledoux, Allison ;
Choi, Young Hae ;
Mes, Jurriaan J. ;
Guan, Xiaonan ;
Molist, Francesc ;
Minh, Tam Pham Thi ;
van der Wielen, Nikkie .
PLOS ONE, 2024, 19 (03)